Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Pharmazie in Unserer Zeit
|
February 6, 1998
[Polymorphism and thermal analysis of pharmaceutical agents]
A Grunenberg
Der Internist
|
February 3, 2016
[Waldenström's macroglobulinemia. Current developments in diagnostics and therapy]
A Grunenberg, C Buske
Plos One
|
July 21, 2017
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
Susan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, et al.
AIDS and Behavior
|
March 17, 2023
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
Mookho Malahleha, Fatima Laher, Athmanundh Dilraj, et al.
Science Translational Medicine
|
November 22, 2019
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
Esper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.
The Lancet. Infectious Diseases
|
January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Saranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Pharmazie in Unserer Zeit
|
February 6, 1998
[Polymorphism and thermal analysis of pharmaceutical agents]
A Grunenberg
Der Internist
|
February 3, 2016
[Waldenström's macroglobulinemia. Current developments in diagnostics and therapy]
A Grunenberg, C Buske
Plos One
|
July 21, 2017
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
Susan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, et al.
AIDS and Behavior
|
March 17, 2023
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
Mookho Malahleha, Fatima Laher, Athmanundh Dilraj, et al.
Science Translational Medicine
|
November 22, 2019
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
Esper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.
The Lancet. Infectious Diseases
|
January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Saranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.
Page
of 1